Treatment of Early Borderline Lesions in Low Immunological Risk Kidney Transplant Patients (TRAINING)

PHASE4RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 5, 2022

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
Kidney Transplant Failure and Rejection
Interventions
DRUG

Grafalon

When Borderline lesions are present in protocol biopsy, administer Grafalon ® 6 mg/kg/day in a single day. Then continue with the normal treatment: Steroids (5 mg/day), tacrolimus (0.1 mg/kg/day) and mycophenolate (1000 mg/day).

DRUG

Normal Treatment

When Borderline lesions are present in protocol biopsy, administer the normal treatment: Steroids (5 mg/day), tacrolimus (0.1 mg/kg/day) and mycophenolate (1000 mg/day)

Trial Locations (4)

29010

RECRUITING

Veronica Lopez Jimenez, Málaga

38320

RECRUITING

Hospital Universitario de Canarias, Santa Cruz de Tenerife

08025

RECRUITING

Fundación Puigvert, Barcelona

08035

RECRUITING

Hospital Universitari Valld´Hebron, Barcelona

All Listed Sponsors
lead

Fundación Canaria de Investigación Sanitaria

OTHER